The Potential of a Novel Class of EPAC-Selective Agonists to Combat Cardiovascular Inflammation. (2017)
Attributed to:
The Cyclic AMP-GEF/C/EBP Pathway; a New PKA-independent Route for the Control of Gene Expression by Cyclic AMP
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/jcdd4040022
PubMed Identifier: 29367551
Publication URI: http://europepmc.org/abstract/MED/29367551
Type: Journal Article/Review
Volume: 4
Parent Publication: Journal of cardiovascular development and disease
Issue: 4
ISSN: 2308-3425